Levodopa therapeutics for Parkinson's disease: new developments
β Scribed by Peter A. LeWitt
- Book ID
- 117753216
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 98 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1353-8020
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Three patients with Parlcinson's disease, optimally treated with levodopdcabidopa (LDKD) tablets, but experiencing severe motor fluctuations, were administered a solution of levodopd carbidopalascorbic acid (LCAS) orally at intervals ranging from 30 to 60 minutes. Patients were rated half-hourly to
F r a n c e . Surgical methods are still of interest when levodopa therapy fails. High frequency stimulation has similar effects and is safer than destruction in several basal ganglia, such as Ventral Intermediate Thalamus (Vim), Subthalamic Nucleus (STN) and Globus Pallidus Internus (GPi) has trigg